4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-054789
Chief Financial Officer sold 37,884 shares at an average $40.85 ($1,547,378)
- Chief Financial Officer acquired 37,884 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2019-11-01 | Option exercise | +37,884 | $7.75 | $293,601 | 351,420 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2019-11-01 | Sale | −21,264 | $40.56 | $862,468 | 330,156 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2019-11-01 | Sale | −16,620 | $41.21 | $684,910 | 313,536 | D |
| Derivatives | |||||||
| Myszkowski Kenneth Allen Chief Financial Officer | 2019-11-01 | Option exercise · Stock Option (right to buy) | −37,884 | 162,116 | D | ||
| Open-market sales · 37,884 sh · avg $40.85 · $1,547,378 | |||||||
Loading xslF345X03/doc4.xml…